Yiyi Yan, MD, PhD

  • 209 Citations
  • 6 Scopus h-Index
20132019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Yiyi Yan is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 4 Similar Profiles
Neoplasms Medicine & Life Sciences
Melanoma Medicine & Life Sciences
Large Granular Lymphocytic Leukemia Medicine & Life Sciences
Immunotherapy Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
T-Lymphocytes Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Neoadjuvant Therapy Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2013 2019

Case series of dabrafenib-trametinib-induced pyrexia successfully treated with colchicine

Vera, J., Paludo, J., Kottschade, L., Brandt, J., Yan, Y., Block, M. S., Mc Williams, R. R., Dronca, R. S., Loprinzi, C. L., Grothey, A. F. & Markovic, S. N., Jan 1 2019, In : Supportive Care in Cancer.

Research output: Contribution to journalArticle

Colchicine
Fever
Mitogen-Activated Protein Kinases
Familial Mediterranean Fever
Therapeutics

Corrigendum to “Targeting B7-H1 (PD-L1) sensitizes cancer cells to chemotherapy” [Heliyon 4 (12) (December 2018) e01039] (Heliyon (2018) 4(12), (S2405844018323442), (10.1016/j.heliyon.2018.e01039))

Wu, X., Li, Y., Liu, X., Chen, C., Harrington, S. M., Cao, S., Xie, T., Pham, T., Mansfield, A., Yan, Y., Kwon, E. D., Wang, L. M., Ling, K. & Dong, H. M., Mar 1 2019, In : Heliyon. 5, 3, e01309.

Research output: Contribution to journalComment/debate

Open Access
Drug Therapy
Neoplasms
corrigendum

Paradox-driven adventures in the development of cancer immunology and immunotherapy

Barham, W., Gicobi, J. K., Yan, Y., Dronca, R. S. & Dong, H. M., Jan 1 2019, (Accepted/In press) In : Genes and Diseases.

Research output: Contribution to journalReview article

Open Access
Immunology
Allergy and Immunology
Immunotherapy
Social Responsibility
Standard of Care

The role of serum lactate dehydrogenase level as a prognostic indicator in resected, high risk melanoma

Kumar, A. B., Aguilera, J. V., Velazquez, A., Yan, Y., Jakub, J. W., Brewer, J., Hieken, T. J., Block, M. S., Mc Williams, R. R., Otley, C., Markovic, S. N. & Kottschade, L., Jan 1 2019, In : Dermatologic Therapy. e12813.

Research output: Contribution to journalLetter

L-Lactate Dehydrogenase
Melanoma
Serum

Understanding heterogeneous tumor microenvironment in metastatic melanoma

Yan, Y., Leontovich, A. A., Gerdes, M. J., Desai, K., Dong, J., Sood, A., Santamaria-Pang, A., Mansfield, A., Chadwick, C., Zhang, R., Nevala, W. K., Flotte, T. J., Ginty, F. & Markovic, S. N., Jun 1 2019, In : PloS one. 14, 6, e0216485.

Research output: Contribution to journalArticle

Open Access
Tumor Microenvironment
melanoma
Tumors
Melanoma
neoplasms